Chemoinformaics analysis of Isovaleric acid, pentadecyl ester
| Molecular Weight | 312.538 | nRot | 16 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 1 |
| Exact Molecular Weight | 312.303 | nRing | 0 |
| Solubility: LogS | -7.059 | nHRing | 0 |
| Solubility: LogP | 8.177 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 61.6757 |
| nHD | 0 | BPOL | 42.7323 |
| QED | 0.235 |
| Synth | 1.948 |
| Natural Product Likeliness | 0.259 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.786 |
| MDCK | 0.0000133 |
| BBB | 0.137 |
| PPB | 0.974787 |
| VDSS | 2.229 |
| FU | 0.0182555 |
| CYP1A2-inh | 0.17 |
| CYP1A2-sub | 0.18 |
| CYP2c19-inh | 0.454 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.181 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.023 |
| CYP3a4-inh | 0.256 |
| CYP3a4-sub | 0.068 |
| CL | 6.576 |
| T12 | 0.144 |
| hERG | 0.256 |
| Ames | 0.004 |
| ROA | 0.029 |
| SkinSen | 0.961 |
| Carcinogencity | 0.062 |
| EI | 0.977 |
| Respiratory | 0.82 |
| NR-Aromatase | 0.027 |
| Antiviral | No |
| Prediction | 0.507827 |